ArticleInternal medicine (Tokyo, Japan)2020

Pembrolizumab for Previously Untreated Patients with Advanced Non-small-cell Lung Cancer and Preexisting Interstitial Lung Disease.

Tetsuo Fujita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.